GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Control
Yahoo Finance · Aug 17, 2026 · AnaptysBio Inc (ANAB)
Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund achieved an approximate 11% net return in the second quarter, indicating progress from the first quarter. Key changes to the portfolio will include lower concentration and increased investments with near-term catalysts, […]
Not investment advice. Cached headline, not a full reprint.